Kevin Puylaert, Chief Sales Officer at SOPHiA GENETICS SA (SOPH), sold 624 shares at $4.86 ($3K) on 2026-04-06, disclosed to the SEC on 2026-04-08.
Open-market sale of $3k SOPH by Chief Sales Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.83 | 30 | $145 | 4.8% |
| 2 | $4.86 | 46 | $224 | 7.4% |
| 3 | $4.86 | 548 | $3K | 87.8% |
| Total | $4.86 avg | 624 | $3K | 100% |
| Filing → |
| SOPH | SELL | 2026-05-20 | $150 | — | Filing → |
| SOPH | SELL | 2026-04-21 | $168 | — | Filing → |
| SOPH | SELL | 2026-04-01 | $14 | — | Filing → |